Global Orthobiologics Market Growth Analysis (2018 – 2023) - Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corporation, DePuy Synthes

The distinct file of Orthobiologics Market evaluated by way of skilled professionals is segmented into application and Product. The Orthobiologics marketplace is anticipated to witness full-size improvement in the following years from 2018-2025.

Browse detailed TOC, Tables, Figures, Charts and Companies mentioned in Global Orthobiologics Market research report: https://www.crystalmarketresearch.com/report/orthobiologics-market .

Industry Trend Analysis:
The orthobiologics market is expected to be around $10 billion by 2025. The market is primarily driven by factors such as increasing number of orthopedic surgical procedures performed worldwide due to rising incidence of accidents and sports related injuries. Increasing prevalence of geriatric population around the world is another key factor contributing to the market growth. According to the 2015 World Aging Population report by the United Nations (UN), between 2015 and 2030, the global population aged 60 years and over is expected to grow by 56% from 901 million to 1.4 billion. This number is projected to further rise up to 2.1 billion by 2050. As geriatric people are more susceptible to orthopedic and spinal disorders, such high prevalence will largely contribute to the growth of orthobiologics market during the forecast period. However, factors such as high cost of the procedures and stringent regulatory approval processes can hinder the growth of orthobiologics market during the forecast period.

Competitive Insights:
The major players in the orthobiologics market focus on new product development strategy to secure a competitive advantage over others. Moreover, they are involved in strategic collaborations, mergers and acquisitions to enhance their presence across different regional markets. For instance, in March 2016, Zimmer Biomet Holdings, Inc. secured an exclusive global distribution agreement with CelgenTek Innovations Corporation for its N-Force Fixation System and CelgenTek's iN3 cement. The agreement enabled CelgenTek to enhance its reach benefiting from Zimmer Biomet’s commercial capabilities.

Some of the key players operating in the orthobiologics market are, Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corporation, DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc.), Medtronic plc, Osiris Therapeutics, Inc., Kuros Biosciences AG, Globus Medical Inc., Wright Medical Group N.V, Arthrex, Inc., ISTO Technologies, Inc., CollPlant Ltd, OsteoMed and NuVasive, Inc.

Market Opportunities:
The key opportunity for the players operating in orthobiologics market lies in the development of advanced reconstruction and repair products. Moreover, expanding distribution capabilities to explore and capture new marketplaces will facilitate a competitive edge for the major players in coming years. Increasing demand for patient specific therapy and rising incidence of spine related disorders will offer lucrative growth opportunities for the orthobiologics market in emerging countries during the next few years.

Request here to grab the SAMPLE Report at: https://www.crystalmarketresearch.com/report-sample/HC06151 .

Orthobiologics Market Segmentation:
By Product:
Demineralized Bone Matrix (DBM)
Viscosupplementation
Bone Morphogenetic Protein (BMP)
Allograft
Stem Cell Therapy
Synthetic Bone Substitutes

By Application:
Trauma Repair
Spinal Fusion
Reconstructive Surgery

By End User:
Orthopedic Clinics
Hospitals

(Early customers will receive 10% customization in this report.)

Place a PURCHASE order of this report at: https://www.crystalmarketresearch.com/checkout/HC06151 .

Regional Outlook and Trend Analysis:
North America dominated the orthobiologics market in 2016 due to the abundant presence of prominent players in orthobiologics market in the region along with favorable reimbursement policies for fusion enhancement products and soft tissue healing. The Asia-Pacific orthobiologics market is expected to grow at the fastest rate over the forecast period owing to increasing healthcare expenditure in emerging countries along with rising disposable income of the people.

By Region: North America: (U.S, Canada & Mexico), Europe: (Germany, France, UK, Italy, Spain & Rest of Europe), Asia-Pacific: (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) and Rest of the World: (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates & Others)

Product Outlook and Trend Analysis:
Viscosupplementation segment dominated the global orthobiologics market in 2016 owing to high adoption of these products for diseases such as hip degenerative joint disease and osteoarthritis. The growth of this market can be further attributed to growing popularity of knee treatments along with the ability of viscosupplementation to act as an effective pain killer as compared to others. Synthetic bone substitutes segment along with stem cell based products is expected to witness significant growth during the forecast period as a result of their reduced cost and associated benefits such as eliminated risk of disease transmission and quick recovery.

Major Table of Contents:
Part 1. Introduction
1.1. Report Description
1.2. Research Methodology

Part 2. Executive Summary
2.1. Key Highlights

Part 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Geriatric Population
3.3.1.2. Rising Incidence of Sports Injuries
3.3.1.3. Increasing Demand for Minimally Invasive Surgical Procedures
3.3.1.4. Surge in the Number of Orthopedic Surgeries
3.3.2. Restraints
3.3.2.1. High Cost of Orthobiologics Related Surgeries
3.3.2.2. Stringent Regulatory Approval Process
3.3.3. Opportunities
3.3.3.1. Emerging Markets to Offer Lucrative Growth Opportunities

Part 4. Orthobiologics Market, By Product
4.1. Introduction
4.2. Orthobiologics Market Assessment and Forecast, By Product, 2016-2025
4.3. Demineralized Bone Matrix
4.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4. Viscosupplementation
4.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.5. Bone Morphogenetic Protein
4.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.6. Allograft
4.6.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.7. Stem Cell Therapy
4.7.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.8. Synthetic Bone Substitutes
4.8.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

Part 5. Orthobiologics Market, By Application
5.1. Introduction
5.2. Orthobiologics Market Assessment and Forecast, By Application, 2016-2025
5.3. Trauma Repair
5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.4. Spinal Fusion
5.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.5. Reconstructive Surgery
5.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

…Read Full Table of Contents

Request the Amazing DISCOUNT Price at: https://www.crystalmarketresearch.com/check-discount/HC06151 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Ph: +1-888-213-4282
Web: https://www.crystalmarketresearch.com

This release was published on openPR.